ZBIO Zenas BioPharma, Inc. - Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 13, 2026
$28,30
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$13,75rendah 52m
$44,60tinggi 52m
Kapitalisasi Pasar (MRQ)
$1.79B
P/E
-3.4
EPS
$-8.44
Pendapatan
$10M
lencana Anda
Rentang 52M
$14–$45
Peringkat Analis
STRONG BUY
Target Harga
$48
P/E
-3.4
ROE
-156.8%
Margin Laba Bersih
-3777.4%
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
ZBIO Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$28.30
Kapitalisasi Pasar (MRQ)
$1.79B
P/E
-3.4
EPS
$-8.44
Pendapatan
$10M
ROE
-156.8%
D/E Utang/Ekuitas
0.3
Rentang 52M
$14–$45
ZBIO Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$10M2023-12-31 → 2025-12-31
EPS$-8.442023-12-31 → 2025-12-31
Arus Kas Bebas$-172M2024-12-31 → 2025-12-31
Margin bersih-3777.4%2024-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | ZBIO | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -3.4 | · | · | · | |
| P/S | 154.2 | · | 7.4 | Terlalu mahal | |
| P/B (MRQ) | 7.3 | · | 5.4 | Terlalu mahal | |
| EV / EBITDA | -3.3 | · | · | · | |
| Harga / FCF (TTM) | -7.9 | · | · | · | |
| Harga / Arus Kas (TTM) | -7.9 | · | · | · | |
| EV / Revenue (EV / Pendapatan) | 127.7 | · | · | · | |
| EV / FCF | -7.4 | · | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 6.4 | · | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | ZBIO | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Operating Margin (Margin Operasi) | -3830.6% | · | 0.56% | Lemah | |
| EBITDA Margin (Margin EBITDA) | -3830.6% | · | 0.56% | Lemah | |
| Pretax Margin (Margin Sebelum Pajak) | -3778.2% | · | -0.44% | Lemah | |
| Net Profit Margin (Margin Laba Bersih) | -3777.4% | · | -1.2% | Lemah | |
| ROA | -100.2% | · | -31.8% | Lemah | |
| ROE | -156.8% | · | -56.5% | Lemah | |
| ROIC | -119.4% | · | -62.3% | Lemah |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | ZBIO | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Debt / Equity (Utang / Ekuitas) | 0.3 | · | 0.2 | Utang tinggi | |
| Rasio Lancar (MRQ) | 9.9 | · | 8.5 | Likuiditas kuat | |
| Quick Ratio (Rasio Cepat) | 5.5 | · | 4.4 | Likuiditas kuat | |
| Long-Term Debt / Equity (Utang Jangka Panjang / Ekuitas) | 0.3 | · | · | · |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | ZBIO | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | 100.0% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | ZBIO | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 0.0 | · | 0.6 | Lemah | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$59.9K | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-89.7%
Laporan Berikutnya
Nov 10, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 18, 2026 | $-1.29 | $-1.15 | -12.5% |
| 31 Maret 2026 | Mei 14, 2026 | $-1.46 | $-1.62 | 9.7% |
| 31 Des. 2025 | $-4.54 | $-1.05 | -333.0% | |
| 30 Sep. 2025 | $-1.22 | $-1.07 | -14.2% | |
| 30 Juni 2025 | $-1.25 | $-1.07 | -16.7% | |
| 31 Maret 2025 | $-0.80 | $-1.13 | 29.3% | |
| 31 Des. 2024 | $-3.99 | $-1.02 | -290.8% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $10M | $5M | $50M | |
| R&D Expense | $168M | $139M | $60M | |
| SG&A Expense | $53M | $30M | $17M | |
| Operating Expenses | $393M | $169M | $87M | |
| Operating Income | $-383M | $-164M | $-37M | |
| Interest Income | $12M | $8M | · | |
| Other Non-op | $417.0K | $202.0K | $624.0K | |
| Pretax Income | $-378M | $-157M | $-37M | |
| Income Tax | $-79.0K | $429.0K | $301.0K | |
| Net Income | $-378M | $-157M | $-37M | |
| EPS (Basic) | $-8.44 | $-11.89 | $-24.25 | |
| EPS (Diluted) | $-8.44 | $-11.89 | $-24.25 | |
| Shares (Basic) | 44,730,052 | 13,198,960 | 1,531,178 | |
| Shares (Diluted) | 44,730,052 | 13,198,960 | 1,531,178 | |
| EBITDA | $-383M | $-164M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $111M | $320M | $57M | |
| Short-term Investments | $233M | $31M | · | |
| Prepaid Expense | $8M | $5M | $3M | |
| Current Assets | $351M | $356M | $60M | |
| PP&E (Net) | $34.0K | $185.0K | $193.0K | |
| Other Non-current Assets | $14M | $13M | $7M | |
| Total Assets | $384M | $370M | $68M | |
| Accounts Payable | $7M | $17M | $5M | |
| Accrued Liabilities | $54M | $39M | $17M | |
| Current Liabilities | $63M | $57M | $23M | |
| Capital Leases | $211.0K | $218.0K | $257.0K | |
| Total Liabilities | $141M | $58M | $44M | |
| Total Debt | $79M | · | · | |
| Common Stock | $5.0K | $4.0K | · | |
| Paid-in Capital | $1.01B | $700M | $5M | |
| Retained Earnings | $-765M | $-387M | $-230M | |
| AOCI | $-64.0K | $194.0K | $37.0K | |
| Stockholders' Equity | $242M | $312M | $-226M | |
| Liabilities + Equity | $384M | $370M | $68M | |
| Shares Outstanding | 54,485,518 | 41,793,412 | 1,576,854 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $26M | $11M | $3M | |
| Operating Cash Flow | $-172M | $-120M | $-31M | |
| CapEx | $18.0K | $131.0K | $17.0K | |
| Investing Cash Flow | $-252M | $-31M | $-17.0K | |
| Financing Cash Flow | $215M | $413M | $20M | |
| Net Change in Cash | $-209M | $263M | $-10M | |
| Taxes Paid | $15.0K | · | · | |
| Free Cash Flow | $-172M | $-120M | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -3830.6% | -3277.8% | · | |
| Net Margin | -3777.4% | -3139.8% | · | |
| Pretax Margin | -3778.2% | -3131.2% | · | |
| EBITDA Margin | -3830.6% | -3277.8% | · | |
| ROA | -100.2% | -71.7% | · | |
| ROE | -156.8% | -46.7% | · | |
| ROIC | -119.4% | -52.6% | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 5.6 | 6.2 | · | |
| Quick Ratio | 5.5 | 6.1 | · | |
| Debt / Equity | 0.3 | · | · | |
| LT Debt / Equity | 0.3 | · | · |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Book Value / Share | $4.44 | $7.48 | · | |
| Revenue / Share | $0.22 | $0.38 | · | |
| Cash Flow / Share | $-3.85 | $-9.07 | · | |
| Cash / Share | $2.03 | $7.65 | · | |
| EPS (TTM) | $-8.44 | $-11.89 | · |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 100.0% | -90.0% | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $10M | $5M | · | |
| Net Income TTM | $-378M | $-157M | · | |
| Market Cap | $1.98B | $342M | · | |
| Enterprise Value | $1.71B | · | · | |
| P/E | -4.3 | -0.7 | · | |
| P/S | 197.8 | 68.5 | · | |
| P/B | 8.2 | 1.1 | · | |
| P / Tangible Book | 8.2 | 1.1 | · | |
| P / Cash Flow | -11.5 | -2.9 | · | |
| P / FCF | -11.5 | -2.9 | · | |
| EV / EBITDA | -4.5 | · | · | |
| EV / FCF | -9.9 | · | · | |
| EV / Revenue | 171.4 | · | · | |
| Earnings Yield | -23.2% | -145.2% | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | · | $0 | $0 | $0 | $10M | $5M | $0 | $0 | · | $0 | $50M | |
| R&D Expense | $63M | $60M | $56M | $34M | $43M | $35M | $49M | $34M | $34M | $23M | $20M | $9M | |
| SG&A Expense | $16M | $17M | $16M | $13M | $12M | $12M | $11M | $7M | $6M | $5M | $4M | $5M | |
| Operating Expenses | $109M | $77M | $238M | $53M | $55M | $47M | $61M | $41M | $40M | $28M | $25M | $14M | |
| Operating Income | $-108M | $-77M | $-238M | $-53M | $-55M | $-37M | $-56M | $-41M | $-40M | $-28M | $-25M | $36M | |
| Interest Income | $7M | $3M | · | · | $3M | $3M | · | · | · | · | · | · | |
| Other Non-op | $16.0K | $-24.0K | $-7M | $1M | $217.0K | $158.0K | $-5M | $2M | $2M | $472.0K | $793.0K | $-16.0K | |
| Pretax Income | $-111M | $-81M | $-240M | $-51M | $-52M | $-34M | $-52M | $-39M | $-38M | $-28M | · | · | |
| Income Tax | $114.0K | · | $106.0K | $0 | $20.0K | $-205.0K | · | · | · | · | · | · | |
| Net Income | $-111M | $-81M | $-240M | $-51M | $-52M | $-34M | $-53M | $-39M | $-38M | $-28M | $-25M | $36M | |
| EPS (Basic) | $-1.77 | $-1.46 | $-5.17 | $-1.22 | $-1.25 | $-0.80 | $35.25 | $-5.02 | $-24.23 | $-17.89 | $-16.04 | $2.42 | |
| EPS (Diluted) | $-1.77 | $-1.46 | $-5.17 | $-1.22 | $-1.25 | $-0.80 | $35.25 | $-5.02 | $-24.23 | $-17.89 | $-16.04 | $1.96 | |
| Shares (Basic) | 63,112,314 | 55,624,631 | · | 42,159,340 | 41,865,400 | 41,800,802 | · | 7,697,695 | 1,567,269 | 1,554,087 | · | 1,537,918 | |
| Shares (Diluted) | 63,112,314 | 55,624,631 | · | 42,159,340 | 41,865,400 | 41,800,802 | · | 7,697,695 | 1,567,269 | 1,554,087 | · | 1,898,391 | |
| EBITDA | $-108M | $-77M | · | $-53M | $-55M | $-37M | · | $-41M | · | · | · | · |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $197M | $500M | $111M | $116M | $44M | $197M | $320M | $360M | · | · | $57M | · | |
| Short-term Investments | $447M | $217M | $233M | $175M | $229M | $116M | $31M | $27M | · | · | · | · | |
| Prepaid Expense | $11M | $13M | $8M | $6M | $5M | $5M | $5M | $7M | · | · | $3M | · | |
| Current Assets | $654M | $730M | $351M | $297M | $279M | $318M | $356M | $394M | · | · | $60M | · | |
| PP&E (Net) | $23.0K | $28.0K | $34.0K | $50.0K | $61.0K | $72.0K | $185.0K | $146.0K | · | · | $193.0K | · | |
| Other Non-current Assets | $16M | $15M | $14M | $14M | $12M | $13M | $13M | $9M | · | · | $7M | · | |
| Total Assets | $702M | $748M | $384M | $322M | $293M | $334M | $370M | $403M | · | · | $68M | · | |
| Accounts Payable | $8M | $9M | $7M | $6M | $8M | $20M | $17M | $15M | · | · | $5M | · | |
| Accrued Liabilities | $57M | $51M | $54M | $45M | $45M | $28M | $39M | $29M | · | · | $17M | · | |
| Current Liabilities | $66M | $61M | $63M | $52M | $53M | $49M | $57M | $44M | · | · | $23M | · | |
| Capital Leases | $22.0K | $77.0K | $211.0K | $180.0K | $215.0K | $317.0K | $218.0K | · | · | · | $257.0K | · | |
| Total Liabilities | $455M | $412M | $141M | $126M | $53M | $49M | $58M | $44M | · | · | $44M | · | |
| Total Debt | · | · | · | $73M | · | · | · | · | · | · | · | · | |
| Common Stock | $6.0K | $6.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | · | · | · | · | |
| Paid-in Capital | $1.21B | $1.18B | $1.01B | $721M | $713M | $705M | $700M | $694M | · | · | $5M | · | |
| Retained Earnings | $-958M | $-846M | $-765M | $-525M | $-473M | $-421M | $-387M | $-335M | · | · | $-230M | · | |
| AOCI | $-1M | $-377.0K | $-64.0K | $-69.0K | $-94.0K | $141.0K | $194.0K | $54.0K | · | · | $37.0K | · | |
| Stockholders' Equity | $247M | $336M | $242M | $196M | $240M | $284M | $312M | $359M | · | · | $-226M | · | |
| Liabilities + Equity | $702M | $748M | $384M | $322M | $293M | $334M | $370M | $403M | · | · | $68M | · | |
| Shares Outstanding | 63,330,747 | 62,383,377 | 54,485,518 | 42,213,465 | 42,088,697 | 41,821,887 | 41,793,412 | 41,780,938 | · | · | 1,576,854 | · |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $9M | $9M | $8M | $7M | $6M | $5M | $5M | $3M | $2M | $947.0K | $1M | · | |
| Operating Cash Flow | $-57M | $-75M | $-52M | $-41M | $-42M | $-37M | $-39M | $-31M | $-31M | $-19M | $-15M | · | |
| CapEx | $0 | $2.0K | $0 | $0 | $0 | $18.0K | $74.0K | $0 | $35.0K | $22.0K | · | · | |
| Investing Cash Flow | $-288M | $32M | $-93M | $40M | $-112M | $-86M | $-4M | $-27M | $-35.0K | $-22.0K | · | · | |
| Financing Cash Flow | $42M | $433M | $141M | $73M | $2M | $99.0K | $2M | $234M | $178M | $-614.0K | $50.0K | · | |
| Net Change in Cash | $-304M | $390M | $-5M | $72M | $-153M | $-123M | $-40M | $176M | $147M | $-20M | $-15M | · | |
| Free Cash Flow | · | $-75M | · | · | · | $-37M | · | · | · | · | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -10765.9% | · | · | · | · | -373.3% | · | · | · | · | · | · | |
| Net Margin | -11145.6% | · | · | · | · | -335.7% | · | · | · | · | · | · | |
| Pretax Margin | -11134.2% | · | · | · | · | -337.8% | · | · | · | · | · | · | |
| EBITDA Margin | -10765.9% | · | · | · | · | -373.3% | · | · | · | · | · | · | |
| ROA | -22.4% | -15.0% | · | -14.2% | -35.6% | -20.1% | · | -19.1% | · | · | · | · | |
| ROE | -45.8% | -26.1% | · | -18.5% | -43.6% | -23.6% | · | -21.5% | · | · | · | · | |
| ROIC | -43.6% | · | · | · | -23.0% | -13.1% | · | · | · | · | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.9 | 11.9 | · | 5.7 | 5.2 | 6.5 | · | 9.0 | · | · | · | · | |
| Quick Ratio | 9.8 | 11.7 | · | 5.5 | 5.1 | 6.4 | · | 8.8 | · | · | · | · | |
| Debt / Equity | · | · | · | 0.4 | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | · | · | · | 0.4 | · | · | · | · | · | · | · | · |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | 0.0 | 0.0 | 0.1 | · | · | · | · | · | · |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.90 | $5.38 | · | $4.65 | $5.69 | $6.80 | · | $8.60 | · | · | · | · | |
| Revenue / Share | $0.02 | · | · | $0.00 | $0.00 | $0.24 | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-1.35 | · | · | · | $-0.89 | · | · | · | · | · | · | |
| Cash / Share | $3.10 | $8.02 | · | $2.74 | $1.05 | $4.70 | · | $8.62 | · | · | · | · | |
| EPS (TTM) | $-9.62 | $-9.10 | · | $31.98 | $28.18 | $5.20 | · | $-63.18 | $-56.20 | · | · | · |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $10M | · | $15M | $15M | $15M | · | · | · | · | · | · | |
| Net Income TTM | $-484M | $-425M | · | $-190M | $-177M | $-163M | · | $-129M | $-55M | $-46M | · | · | |
| Market Cap | $1.61B | $1.22B | · | $937M | $408M | $330M | · | $707M | · | · | · | · | |
| Enterprise Value | · | · | · | $719M | · | · | · | · | · | · | · | · | |
| P/E | -2.6 | -2.1 | · | 0.7 | 0.3 | 1.5 | · | -0.3 | · | · | · | · | |
| P/S | · | 122.0 | · | 62.5 | 27.2 | 22.0 | · | · | · | · | · | · | |
| P/B | 6.5 | 3.6 | · | 4.8 | 1.7 | 1.2 | · | 2.0 | · | · | · | · | |
| P / Tangible Book | 6.5 | 3.6 | · | 4.8 | 1.7 | 1.2 | · | 2.0 | · | · | · | · | |
| P / Cash Flow | · | -16.2 | · | · | · | -8.9 | · | · | · | · | · | · | |
| EV / Revenue | · | · | · | 47.9 | · | · | · | · | · | · | · | · | |
| Earnings Yield | -37.9% | -46.6% | · | 144.0% | 290.8% | 65.8% | · | -373.4% | · | · | · | · |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Pendapatan | $10M | $5M | $50M |
| Margin Operasi % | -3830.6% | -3277.8% | · |
| Laba Bersih | $-378M | $-157M | $-37M |
| EPS Dilusian | $-8.44 | $-11.89 | $-24.25 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Utang / Ekuitas | 0.3 | · | · |
| Rasio Lancar | 5.6 | 6.2 | · |
| Rasio Cepat | 5.5 | 6.1 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Arus Kas Bebas | $-172M | $-120M | · |
Pemilik institusional (13F) 150 pengaju · $1.6B total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
150
Nilai yang dipegang
$1.6B
Posisi baru
27
Posisi yang keluar
21
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 27 (-25 vs Kuartal sebelumnya) | 21 (-13 vs Kuartal sebelumnya) | 65 (+2 vs Kuartal sebelumnya) | 39 (+23 vs Kuartal sebelumnya) | +3.6M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| FMR LLC | $241.280.071 | 9.506.701 | 15,37% | Saham |
| SR One Capital Management, LP | $127.860.735 | 5.037.854 | 8,15% | Saham |
| NEA Management Company, LLC | $102.109.298 | 4.023.219 | 6,50% | Saham |
| ENAVATE SCIENCES GP, LLC | $99.468.255 | 3.919.159 | 6,34% | Saham |
| FEDERATED HERMES, INC. | $79.104.511 | 3.116.805 | 5,04% | Saham |
| BlackRock, Inc. | $68.176.389 | 2.686.225 | 4,34% | Saham |
| Capital International Investors | $63.523.907 | 2.502.912 | 4,05% | Saham |
| Polar Capital Holdings Plc | $61.236.153 | 2.412.772 | 3,90% | Saham |
| Royalty Pharma Sub-Manager, LLC | $60.611.247 | 2.388.150 | 3,86% | Saham |
| Fairmount Funds Management LLC | $59.872.055 | 2.359.025 | 3,81% | Saham |
| VANGUARD GROUP INC | $52.760.791 | 1.453.065 | 3,36% | Saham |
| STATE STREET CORP | $52.158.438 | 2.055.100 | 3,32% | Saham |
| NVP ASSOCIATES, LLC | $46.660.673 | 1.838.482 | 2,97% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $40.451.126 | 1.593.819 | 2,58% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $34.386.448 | 1.354.864 | 2,19% | Saham |
| BANK OF AMERICA CORP /DE/ | $31.246.815 | 1.231.159 | 1,99% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $22.406.450 | 882.654 | 1,43% | Saham |
| ALLIANCEBERNSTEIN L.P. | $21.571.235 | 1.103.388 | 1,37% | Saham |
| TWO SIGMA INVESTMENTS, LP | $20.688.507 | 815.150 | 1,32% | Saham |
| EcoR1 Capital, LLC | $20.037.510 | 789.500 | 1,28% | Saham |
| MILLENNIUM MANAGEMENT LLC | $16.762.729 | 660.470 | 1,07% | Saham |
| Woodline Partners LP | $14.987.880 | 590.539 | 0,95% | Saham |
| Balyasny Asset Management L.P. | $14.637.077 | 576.717 | 0,93% | Saham |
| ArrowMark Colorado Holdings LLC | $14.550.811 | 573.318 | 0,93% | Saham |
| SILVERARC CAPITAL MANAGEMENT, LLC | $12.938.445 | 509.789 | 0,82% | Saham |
| Rock Springs Capital Management LP | $12.742.714 | 502.077 | 0,81% | Saham |
| Pivotal bioVenture Partners Investment Advisor LLC | $12.455.641 | 490.766 | 0,79% | Saham |
| NEXTBio Capital Management LP | $10.830.560 | 426.736 | 0,69% | Saham |
| Vestal Point Capital, LP | $9.263.700 | 365.000 | 0,59% | Saham |
| MARSHALL WACE, LLP | $8.208.957 | 323.442 | 0,52% | Saham |
| JENNISON ASSOCIATES LLC | $7.970.564 | 314.049 | 0,51% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $7.737.601 | 304.870 | 0,49% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $7.666.917 | 302.085 | 0,49% | Saham |
| NORTHERN TRUST CORP | $7.135.334 | 281.140 | 0,45% | Saham |
| GOLDMAN SACHS GROUP INC | $6.882.117 | 271.163 | 0,44% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $6.462.332 | 254.623 | 0,41% | Saham |
| SPHERA FUNDS MANAGEMENT LTD. | $5.858.567 | 230.834 | 0,37% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.740.956 | 226.200 | 0,37% | Opsi beli |
| Walleye Capital LLC | $5.305.689 | 209.050 | 0,34% | Saham |
| Sio Capital Management, LLC | $5.293.177 | 208.557 | 0,34% | Saham |
| CITADEL ADVISORS LLC | $4.968.897 | 195.780 | 0,32% | Saham |
| UBS Group AG | $4.519.899 | 178.089 | 0,29% | Saham |
| Voleon Capital Management LP | $4.242.140 | 167.145 | 0,27% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $3.834.563 | 151.086 | 0,24% | Saham |
| MORGAN STANLEY | $3.425.767 | 134.979 | 0,22% | Saham |
| Squarepoint Ops LLC | $3.177.195 | 125.185 | 0,20% | Saham |
| BARCLAYS PLC | $2.943.193 | 115.965 | 0,19% | Saham |
| SEVEN GRAND MANAGERS, LLC | $2.538.000 | 100.000 | 0,16% | Saham |
| Birchview Capital, LP | $2.375.593 | 93.601 | 0,15% | Saham |
| Verition Fund Management LLC | $1.852.435 | 72.988 | 0,12% | Saham |
Aktivis & pemilik 5%+ 4 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Enavate Sciences GP, LLC, Zebra Aggregator, LP ×3 pengajuan | 19 Agu 2026 | 4,90% | Amandemen | · | SEC |
| SR One Capital Management, LLC, SR One Capital Fund II Aggregator, LP, SR One Capital Partners II, LP, AMZL, LP, SR One Capital SMA Partners, LP, SR One Capital Opportunities Fund I, LP, SR One Capital Opportunities Partners I, LP, Simeon George ×3 pengajuan | 17 Agu 2026 | 7,70% | Amandemen | · | SEC |
| MOULDER LEON O JR, Tellus BioVentures, LLC, Leon O. Moulder, Jr. Revocable Trust U/A dtd 9/9/2008 ×5 pengajuan | 5 Mei 2026 | 5,09% | Pengajuan awal | Investasi pasif | SEC |
| Longitude Capital Partners IV, LLC, Longitude Venture Partners IV, L.P., Longitude Prime Partners, LLC, Longitude Prime Fund, L.P., Patrick G. Enright, Juliet Tammenoms Bakker ×2 pengajuan | 14 Okt. 2025 | 4,90% | Amandemen | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 14 orang dalam · 5 pejabat · 9 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| MOULDER LEON O JR | Chief Executive Officer | 15 Juni 2026 A | 96.928 | 10 | 0 | $6.533.809 |
| Jennifer A. Fox | Chief Business Officer and Chief Financial Officer | 15 Juni 2026 A | 1.592 | 0 | 0 | $0 |
| Joseph L Farmer | President and Chief Operating Officer | 15 Juni 2026 A | 974 | 0 | 0 | $0 |
| Lisa Von Moltke | Head of Research and Development and Chief Medical Officer | 15 Juni 2026 A | · | 0 | 0 | $0 |
| Orlando Oliveira | Chief Commercial Officer | 10 Juni 2025 A | · | 0 | 0 | $0 |
| Christy J. Oliger | Direktur | 1 Sep. 2026 A | · | 0 | 0 | $0 |
| James P Boylan | Direktur | 15 Juni 2026 A | · | 0 | 0 | $0 |
| Hongbo Lu | Direktur | 15 Juni 2026 A | 426.736 | 5 | 0 | $8.154.891 |
| John J Orloff | Direktur | 15 Juni 2026 A | · | 0 | 0 | $0 |
| Jason Raleigh Nunn | Direktur | 15 Juni 2026 A | 1.173.395 | 1 | 0 | $1.200.002 |
| Patricia L Allen | Direktur | 15 Juni 2026 A | 19.860 | 4 | 0 | $499.746 |
| Patrick G. Enright | Direktur | 15 Juni 2026 A | 11.990 | 2 | 0 | $2.250.027 |
| Ting Xiao | Direktur | 7 Feb. 2025 P | 10.000 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | Pemilik 10% | 16 Sep. 2024 C | 801.624 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 26 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 1,06% | 15.697 NS | 31 Juli 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,29% | 45.855 NS | 31 Juli 2026 | N-PORT |
| IWC · iShares Trust | 0,21% | 96.766 SH | 11 Sep. 2026 | Harian |
| FFSM · FIDELITY COVINGTON TRUST | 0,14% | 66.271 NS | 31 Juli 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,12% | 4.609 SH | 1 Okt. 2026 | Harian |
| PWS · Pacer Funds Trust | 0,08% | 626 NS | 31 Juli 2026 | N-PORT |
| IBB · iShares Trust | 0,07% | 242.500 SH | 11 Sep. 2026 | Harian |
| IWO · iShares Trust | 0,06% | 267.610 SH | 11 Sep. 2026 | Harian |
| VFMO · VANGUARD WELLINGTON FUND | 0,04% | 27.907 SH | 19 Agu 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,04% | 30.536 SH | 19 Agu 2026 | Harian |
| PKW · Invesco Exchange-Traded Fund Trust | 0,04% | 24.179 SH | 1 Okt. 2026 | Harian |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,04% | 8.226 NS | 31 Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,03% | 731.217 SH | 11 Sep. 2026 | Harian |
| RSSL · Global X Funds | 0,03% | 13.640 NS | 31 Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 164.002 SH | 19 Agu 2026 | Harian |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 12.595 NS | 31 Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 435.390 SH | 19 Agu 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,01% | 79.801 SH | 19 Agu 2026 | Harian |
| WSML · iShares Trust | 0,01% | 1.983 SH | 11 Sep. 2026 | Harian |
| ITOT · iShares Trust | 0,00% | 58.983 SH | 11 Sep. 2026 | Harian |
| DFAS · Dimensional ETF Trust | 0,00% | 4.511 NS | 31 Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 4.761 SH | 11 Sep. 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 891.196 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.624 SH | 19 Agu 2026 | Harian |
| ISCB · iShares Trust | · | 1.340 SH | 11 Sep. 2026 | Harian |
| ISCV · iShares Trust | · | 6.636 SH | 11 Sep. 2026 | Harian |
ZBIO Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 14 analis
BELI
Target median
$46.50
+64,3%
7 50,0%
Beli Kuat
5 35,7%
Beli
2 14,3%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
8 analis · 2026-10-03Target rata-rata $47.88 +69,2%
← Di bawah semua target
Harga saat ini $28.30
Rendah$32.00
Rata-rata$47.88
Tinggi$59.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| ZBIO | $1.98B | -4.3 | 100.0% | -3777.4% | -156.8% | · |
| VERA | · | -10.9 | · | · | -55.9% | · |
| ADMA | $4.34B | 30.4 | 19.6% | 28.8% | 33.6% | 57.4% |
| MLYS | $2.96B | -15.8 | · | · | -32.2% | · |
| BCRX | $1.66B | 6.4 | 94.1% | 30.2% | -97.6% | · |
| VCEL | $1.82B | 112.5 | 16.4% | 6.0% | 5.0% | 74.4% |
| BHVN | $1.50B | -1.6 | · | · | -310.8% | · |
| PVLA | $1.30B | -28.2 | 65.3% | -1610.6% | -110.1% | · |
| ABSI | $529M | -4.2 | -38.2% | -4113.7% | -63.5% | · |
| AGIO | $1.59B | -3.8 | 48.0% | -764.0% | -32.2% | · |
| VIR | $841M | -1.9 | -7.6% | -638.9% | -51.1% | · |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 13, 2026